Jan 16, 2020 / 05:30PM GMT
Unidentified Analyst -
Hi, everyone. Thanks for joining us today. My name is [Lilli Lazada]. I'm part of the Medtech equity research team here at JPMorgan. After the presentation, we'll be having a breakout session in the Sussex room.
And without further ado, it's my pleasure to introduce AtriCure's CEO, Mike Carrel.
Michael H. Carrel - AtriCure, Inc. - CEO, President & Director
Hello, everyone. I'm Mike Carrel. Thank you, JPMorgan, for having us here and -- on a lovely Thursday morning. So it's been nice all week, for those of you that are online. But today, it's not so nice with the rain. I'm Mike Carrel, President and CEO of AtriCure. I'll kind of talk to you kind of about the exciting things we've got going on in our business.
As you can see from just looking at the first slide is really what we've been doing over the last 10-plus years is creating a platform, a world-class platform for atrial fibrillation. That is what we do. That's what we're about. I'll talk a little bit about the disease and kind of how we approach this state. And
AtriCure Inc at JPMorgan Healthcare Conference Transcript
Feb 06, 2024
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers